XENE

Xenon Pharmaceuticals Inc.

Healthcare›Biotechnology|NASDAQ Global Market|CA

Price

$56.85

Market Cap

$4.49B

Beta

0.94

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-44.37%

Revenue CAGR 3Y-7.36%

P/E Ratio0.0

PEG Ratio—

FCF Yield-6.24%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for XENE.